Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 203

1.

Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.

Jiang FX, Lan Q, Le WJ, Su XH.

BMC Infect Dis. 2017 May 25;17(1):366. doi: 10.1186/s12879-017-2472-z.

2.

Azithromycin Resistance and Decreased Ceftriaxone Susceptibility in Neisseria gonorrhoeae, Hawaii, USA.

Papp JR, Abrams AJ, Nash E, Katz AR, Kirkcaldy RD, O'Connor NP, O'Brien PS, Harauchi DH, Maningas EV, Soge OO, Kersh EN, Komeya A, Tomas JE, Wasserman GM, Kunimoto GY, Trees DL, Whelen AC.

Emerg Infect Dis. 2017 May;23(5):830-832. doi: 10.3201/eid2305.170088.

3.

Gonorrhea - an evolving disease of the new millennium.

Hill SA, Masters TL, Wachter J.

Microb Cell. 2016 Sep 5;3(9):371-389. doi: 10.15698/mic2016.09.524. Review.

4.

Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.

Wind CM, Schim van der Loeff MF, van Dam AP, de Vries HJ, van der Helm JJ.

Euro Surveill. 2017 Jan 5;22(1). pii: 30431. doi: 10.2807/1560-7917.ES.2017.22.1.30431.

5.

Gentamicin versus ceftriaxone for the treatment of gonorrhoea (G-TOG trial): study protocol for a randomised trial.

Brittain C, Childs M, Duley L, Harding J, Hepburn T, Meakin G, Montgomery AA, Tan W, Ross JD.

Trials. 2016 Nov 24;17(1):558.

6.

Risk Factors associated with Paraurethral Duct Dilatation following Gonococcal Paraurethral Duct Infection in Men.

Fan W, Zhang Q, Wang L, Ye X, Jiang T.

PLoS One. 2016 Nov 18;11(11):e0166355. doi: 10.1371/journal.pone.0166355. eCollection 2016.

7.

Gentamicin Susceptibility among a Sample of Multidrug-Resistant Neisseria gonorrhoeae Isolates in India.

Bala M, Singh V, Bhargava A, Kakran M, Joshi NC, Bhatnagar R.

Antimicrob Agents Chemother. 2016 Nov 21;60(12):7518-7521. Print 2016 Dec.

8.

Genomic Epidemiology of Gonococcal Resistance to Extended-Spectrum Cephalosporins, Macrolides, and Fluoroquinolones in the United States, 2000-2013.

Grad YH, Harris SR, Kirkcaldy RD, Green AG, Marks DS, Bentley SD, Trees D, Lipsitch M.

J Infect Dis. 2016 Nov 15;214(10):1579-1587. Epub 2016 Sep 16.

9.

Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational study.

De Silva D, Peters J, Cole K, Cole MJ, Cresswell F, Dean G, Dave J, Thomas DR, Foster K, Waldram A, Wilson DJ, Didelot X, Grad YH, Crook DW, Peto TE, Walker AS, Paul J, Eyre DW.

Lancet Infect Dis. 2016 Nov;16(11):1295-1303. doi: 10.1016/S1473-3099(16)30157-8. Epub 2016 Jul 12.

10.

Time to clearance of Chlamydia trachomatis RNA and DNA after treatment in patients coinfected with Neisseria gonorrhoeae - a prospective cohort study.

Wind CM, Schim van der Loeff MF, Unemo M, Schuurman R, van Dam AP, de Vries HJ.

BMC Infect Dis. 2016 Oct 11;16(1):554.

11.

Emerging azithromycin-resistance among the Neisseria gonorrhoeae strains isolated in Hungary.

Brunner A, Nemes-Nikodem E, Jeney C, Szabo D, Marschalko M, Karpati S, Ostorhazi E.

Ann Clin Microbiol Antimicrob. 2016 Sep 20;15(1):53. doi: 10.1186/s12941-016-0166-9.

12.

Time-kill curve analysis and pharmacodynamic modelling for in vitro evaluation of antimicrobials against Neisseria gonorrhoeae.

Foerster S, Unemo M, Hathaway LJ, Low N, Althaus CL.

BMC Microbiol. 2016 Sep 17;16:216. doi: 10.1186/s12866-016-0838-9.

14.

Molecular epidemiology of drug-resistant Neisseria gonorrhoeae in Russia (Current Status, 2015).

Kubanov A, Vorobyev D, Chestkov A, Leinsoo A, Shaskolskiy B, Dementieva E, Solomka V, Plakhova X, Gryadunov D, Deryabin D.

BMC Infect Dis. 2016 Aug 9;16:389. doi: 10.1186/s12879-016-1688-7.

15.

Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.

Jabeen K, Bhawan Mal P, Khan E, Chandio S, Jacobsson S, Unemo M.

BMC Infect Dis. 2016 Jul 22;16:353. doi: 10.1186/s12879-016-1673-1.

16.

Multiplex Real-Time PCR Assay with High-Resolution Melting Analysis for Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae.

DonĂ  V, Kasraian S, Lupo A, Guilarte YN, Hauser C, Furrer H, Unemo M, Low N, Endimiani A.

J Clin Microbiol. 2016 Aug;54(8):2074-81. doi: 10.1128/JCM.03354-15. Epub 2016 May 25.

17.

Technological Solutions to Address Drug-Resistant Neisseria gonorrhoeae.

Bristow CC, Dong H, Klausner JD.

Emerg Infect Dis. 2016 May;22(5):939-40. doi: 10.3201/eid2205.160083. No abstract available.

18.

Azithromycin-resistant Neisseria gonorrhoeae isolates in Guangzhou, China (2009-2013): coevolution with decreased susceptibilities to ceftriaxone and genetic characteristics.

Liang JY, Cao WL, Li XD, Bi C, Yang RD, Liang YH, Li P, Ye XD, Chen XX, Zhang XB.

BMC Infect Dis. 2016 Apr 14;16:152. doi: 10.1186/s12879-016-1469-3.

19.

New Ceftriaxone- and Multidrug-Resistant Neisseria gonorrhoeae Strain with a Novel Mosaic penA Gene Isolated in Japan.

Nakayama S, Shimuta K, Furubayashi K, Kawahata T, Unemo M, Ohnishi M.

Antimicrob Agents Chemother. 2016 Jun 20;60(7):4339-41. doi: 10.1128/AAC.00504-16. Print 2016 Jul.

20.

Genomic Epidemiology and Molecular Resistance Mechanisms of Azithromycin-Resistant Neisseria gonorrhoeae in Canada from 1997 to 2014.

Demczuk W, Martin I, Peterson S, Bharat A, Van Domselaar G, Graham M, Lefebvre B, Allen V, Hoang L, Tyrrell G, Horsman G, Wylie J, Haldane D, Archibald C, Wong T, Unemo M, Mulvey MR.

J Clin Microbiol. 2016 May;54(5):1304-13. doi: 10.1128/JCM.03195-15. Epub 2016 Mar 2.

Supplemental Content

Loading ...
Support Center